Inducing Compliance with Postmarket Studies for Drugs Under FDA’s Accelerated Approval Pathway

Problem definition: In 1992, the Food and Drug Administration (FDA) instituted the accelerated approval pathway (AP) to allow promising drugs to enter the market based on limited evidence of effica...